FI973571A - Ny växtfaktor och en genetisk sekvens som kodar den - Google Patents

Ny växtfaktor och en genetisk sekvens som kodar den Download PDF

Info

Publication number
FI973571A
FI973571A FI973571A FI973571A FI973571A FI 973571 A FI973571 A FI 973571A FI 973571 A FI973571 A FI 973571A FI 973571 A FI973571 A FI 973571A FI 973571 A FI973571 A FI 973571A
Authority
FI
Finland
Prior art keywords
sequence encoding
genetic sequence
new plant
plant factor
molecule
Prior art date
Application number
FI973571A
Other languages
English (en)
Finnish (fi)
Other versions
FI120153B (sv
FI973571A0 (sv
Inventor
Nicholas Kim Hayward
Gunther Weber
Sean Grimmond
Magnus Nordenskjold
Catharina Larsson
Original Assignee
Amrad Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN1457A external-priority patent/AUPN145795A0/en
Priority claimed from AUPN6647A external-priority patent/AUPN664795A0/en
Priority claimed from AUPN7274A external-priority patent/AUPN727495A0/en
Application filed by Amrad Operations Pty Ltd filed Critical Amrad Operations Pty Ltd
Publication of FI973571A0 publication Critical patent/FI973571A0/sv
Publication of FI973571A publication Critical patent/FI973571A/sv
Application granted granted Critical
Publication of FI120153B publication Critical patent/FI120153B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
FI973571A 1995-03-02 1997-09-01 En ny växtfaktor och en för denna kodande gensekvens FI120153B (sv)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
AUPN1457A AUPN145795A0 (en) 1995-03-02 1995-03-02 A novel growth factor and a genetic sequence encoding same
AUPN145795 1995-03-02
AUPN6647A AUPN664795A0 (en) 1995-11-20 1995-11-20 A novel growth factor and a genetic sequence encoding same
AUPN664795 1995-11-20
AUPN7274A AUPN727495A0 (en) 1995-12-22 1995-12-22 A novel growth factor and a genetic sequence encoding same-II
AUPN727495 1995-12-22
AU9600094 1996-02-22
PCT/AU1996/000094 WO1996027007A1 (en) 1995-03-02 1996-02-22 A novel growth factor and a genetic sequence encoding same

Publications (3)

Publication Number Publication Date
FI973571A0 FI973571A0 (sv) 1997-09-01
FI973571A true FI973571A (sv) 1997-10-30
FI120153B FI120153B (sv) 2009-07-15

Family

ID=27157841

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973571A FI120153B (sv) 1995-03-02 1997-09-01 En ny växtfaktor och en för denna kodande gensekvens

Country Status (16)

Country Link
US (1) US20070135344A1 (sv)
EP (1) EP0815221B1 (sv)
JP (2) JPH11500139A (sv)
KR (1) KR100414615B1 (sv)
CN (1) CN1194090C (sv)
AT (1) ATE252600T1 (sv)
BR (1) BR9607628A (sv)
CA (1) CA2214439C (sv)
DE (1) DE69630442T2 (sv)
ES (1) ES2206558T3 (sv)
FI (1) FI120153B (sv)
HK (1) HK1002963A1 (sv)
HU (1) HU223438B1 (sv)
NO (1) NO320839B1 (sv)
NZ (2) NZ301611A (sv)
WO (1) WO1996027007A1 (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
CA2224002A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Human vascular endothelial growth factor 3
EP0848755B2 (en) 1995-09-08 2011-02-09 Genentech, Inc. Vegf-related protein
ATE459715T1 (de) 1995-09-29 2010-03-15 Univ Siena Regulierte gene und ihre verwendungen
US6994989B1 (en) 1995-11-08 2006-02-07 Immunex Corp. FLK-1 binding proteins
AU1116297A (en) 1995-11-08 1997-05-29 Immunex Corporation Flk-1 binding protein
ES2251740T3 (es) 1996-08-23 2006-05-01 Ludwig Institute For Cancer Research Factor de crecimiento de celulas de endotelio vascular d recombinante (vegf-d).
CN1680442A (zh) * 1997-04-25 2005-10-12 科莱特诺医疗公司 截短的vegf相关蛋白质
NZ505955A (en) 1998-02-06 2005-04-29 Collateral Therapeutics Inc Variants of the angiogenic factor vascular endothelial cell growth factor: VEGF-A, and pharmaceutical use
US7105481B2 (en) 1998-11-10 2006-09-12 Ludwig Institute For Cancer Research Method for stimulating connective tissue growth or wound healing
CA2349951A1 (en) 1998-11-10 2000-05-18 Ludwig Institute For Cancer Research Platelet-derived growth factor d, dna coding therefor, and uses thereof
JP4739526B2 (ja) 1998-12-07 2011-08-03 ザイモジェネティクス， インコーポレイテッド 成長因子相同体ｚｖｅｇｆ３
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
AUPQ568100A0 (en) * 2000-02-16 2000-03-09 Amrad Operations Pty. Limited A method for producing recombinant molecules
US7026462B2 (en) 2000-12-07 2006-04-11 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7981863B2 (en) * 2001-09-19 2011-07-19 Neuronova Ab Treatment of Parkinson's disease with PDGF
CA2599004C (en) 2005-02-28 2015-05-26 Sangamo Biosciences, Inc. Anti-angiogenic methods and compositions
CN100448892C (zh) * 2006-08-02 2009-01-07 中国人民解放军军事医学科学院基础医学研究所 抗肿瘤血管内皮生长因子受体vegf－r2抗原及其编码基因与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073492A (en) * 1987-01-09 1991-12-17 The Johns Hopkins University Synergistic composition for endothelial cell growth
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5219739A (en) * 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
US5338671A (en) * 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
DE69434538T2 (de) * 1994-03-08 2006-08-10 Human Genome Sciences, Inc. Vaskulärer endothelialer Wachstumsfaktor 2
US5607918A (en) * 1995-03-01 1997-03-04 Ludwig Institute For Cancer Research Vascular endothelial growth factor-B and DNA coding therefor
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor

Also Published As

Publication number Publication date
NZ337634A (en) 2001-06-29
HUP9800377A3 (en) 2000-12-28
NO974035D0 (no) 1997-09-02
NZ301611A (en) 2000-02-28
CA2214439A1 (en) 1996-09-06
US20070135344A1 (en) 2007-06-14
HUP9800377A1 (hu) 1998-06-29
CA2214439C (en) 2002-12-17
HK1002963A1 (en) 1998-09-30
KR100414615B1 (ko) 2004-05-27
DE69630442D1 (de) 2003-11-27
BR9607628A (pt) 1999-11-30
EP0815221A4 (en) 1998-12-09
EP0815221B1 (en) 2003-10-22
NO320839B1 (no) 2006-01-30
FI120153B (sv) 2009-07-15
KR19980702702A (ko) 1998-08-05
JP2001037493A (ja) 2001-02-13
JPH11500139A (ja) 1999-01-06
ES2206558T3 (es) 2004-05-16
FI973571A0 (sv) 1997-09-01
CN1224464A (zh) 1999-07-28
NO974035L (no) 1997-11-03
DE69630442T2 (de) 2004-08-19
HU223438B1 (hu) 2004-07-28
CN1194090C (zh) 2005-03-23
ATE252600T1 (de) 2003-11-15
WO1996027007A1 (en) 1996-09-06
JP3683778B2 (ja) 2005-08-17
EP0815221A1 (en) 1998-01-07

Similar Documents

Publication Publication Date Title
FI973571A (sv) Ny växtfaktor och en genetisk sekvens som kodar den
ATE184613T1 (de) Varianten des grünen fluoreszenzproteins, gfp
DE69434312D1 (de) Regulierung von pflanzenwachstum
ATE189475T1 (de) Wachstums-differenzierungsfaktor der tgf-b familie
DE69602638T2 (de) Naphthylverbindungen, Zwischenprodukte, Zusammensetzungen und Methoden
CY1107447T1 (el) Ετερολογη εκφραση πρωτεϊνων των neisseria
DK0825847T3 (da) Tandrensningspræparater
MY148081A (en) Cultivated agarwood
HRP20010036B1 (en) Neurotrophic growth factor
NO971875D0 (no) Cathepsin 02 protease
DE69636495D1 (de) Multi-tumor abweichende wachstumsgene
ATE360701T1 (de) Putrescin-n-methyltransferasepromotor
DE50004334D1 (de) Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane
DE69328025T2 (de) Dorsalgewebe beeinflussender faktor und zusammensetzungen
AU8738401A (en) Novel kallikrein gene
DE50111331D1 (de) Neue verwendung von proteinhydrolysaten
BR9711540A (pt) Inibidores de protease proteìnico estabilizados e variantes dos mesmos
DE69938130D1 (de) Neue peptide
FI944563A0 (sv) Mikroorganismer, framställningsförfarande och användning
DE69838615D1 (de) ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN
FR2676059B1 (fr) Nouveaux derives de peptides utilisables comme inhibiteurs de collagenases bacteriennes.
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
DE60038735D1 (de) Pseudomycin analoge
DE60007991D1 (de) Verwendung des proteins uk 114 zur verhinderung der abstossung eines transplantierten organs
ES1023598Y (es) Nueva boca de riego.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120153

Country of ref document: FI

MA Patent expired